Leanna M. Slarsky
FDA investigator
Appears on 3 documents from 2021 to 2022, mostly at sites in Massachusetts. Most often cites insanitary conditions (FDCA 501(a)(2)(A)).
- 3
- Documents on file
- 7.0
- Observations per 483
- 2021
- First seen
- 2022
- Most recent
What they cite most
From 21 observations- FDCA 501(a)(2)(A)Insanitary conditions6
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
Activity by year
2021: 1, 2022: 2
Where
Massachusetts 2 · New Jersey 1
Often inspects with
Is Leanna M. Slarsky coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-03-24 | 483 Wedgewood Village Pharmacy, LLCMar 24, 2022 · Swe d e sbor o, New Jersey | Swe d e sbor o, New Jersey | 8 | |
| 2022-02-10 | 483 Pharmasol CorporationFeb 10, 2022 · South Easton, Massachusetts | South Easton, Massachusetts | 9 | |
| 2021-11-30 | 483 Catalent Massachusetts, LLCNov 30, 2021 · Chelsea, Massachusetts | Chelsea, Massachusetts | 4 |
About this profile
What does Leanna M. Slarsky inspect?
Leanna M. Slarsky appears on 3 documents on file covering 3 sites, mostly in Massachusetts.
What do they cite most often?
FDCA 501(a)(2)(A) (insanitary conditions), followed by 21 CFR 211.113 and 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Leanna M. Slarsky is dated Mar 24, 2022.